Fig. 5From: Patterns of recurrence after surgery and efficacy of salvage therapy after recurrence in patients with thoracic esophageal squamous cell carcinomaTarget contouring and planning design for elective field radiotherapy after recurrence. GTVnd (pink area), CTV (blue area), PGTVnd (sky blue area), PTV (green area). The prescribed dose (SIB-IMRT) for 95% PTV was 50.4 Gy/1.8 Gy/28 f, and for 95% PGTVnd was 61.88 Gy/2.21 Gy/28 f. The concurrent chemotherapy regimen included liposomal paclitaxel (135 mg/m2 IV) on day 1 and nedaplatin (50 mg/m2 IV) on day 1, which were cycled every 21 days. A total of 2 cycles were deliveredBack to article page